Degradation and inactivation of rat atrial natriuretic peptide 1–28 by neutral endopeptidase-24.11 in rat pulmonary membranes
- 20 November 1992
- journal article
- Published by Elsevier in Regulatory Peptides
- Vol. 42 (1-2) , 85-96
- https://doi.org/10.1016/0167-0115(92)90026-q
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Radio-immunoassay of atrial natriuretic peptide (ANP) and characterization of ANP immunoreactivity in human plasma and atrial tissueScandinavian Journal of Clinical and Laboratory Investigation, 1992
- Antihypertensive and Renal Activity of SQ 28,603, an Inhibitor of Neutral EndopeptidaseJournal of Cardiovascular Pharmacology, 1991
- Degradation and clearance of atrial natriuretic factors (ANF)Life Sciences, 1990
- Enkephalinase (EC 3.4.24.11) inhibitors: Protection of endogenous ANF against inactivation and potential therapeutic applicationsLife Sciences, 1990
- Atrial natriuretic polypeptide is removed by the lungs and released into the left atrium as well as the right atrium in humansJournal of the American College of Cardiology, 1990
- Synthesis and biological activity of atrial natriuretic factor analogs: effect of modifications to the disulfide bridgeJournal of Medicinal Chemistry, 1990
- Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor.Hypertension, 1990
- Atrial natriuretic peptide: its mechanism of release from the atriumInternational Journal of Cardiology, 1989
- Atrial natriuretic peptides cleaved by endopeptidase are inactive in conscious spontaneously hypertensive ratsLife Sciences, 1988
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981